You are here

Supreme Pharmaceuticals Inc.

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
SL
CSE Index: 
Currency: 

Supreme Pharmaceuticals Inc. ("Supreme") (CSE:SL; OTCBB:SPRWF) is a publicly traded marijuana company based in Toronto, Canada. Supreme’s wholly owned subsidiary, 7ACRES/AMMcan, was issued a Canadian federal license to cultivate medical marijuana pursuant to the Marihuana for Medical Purposes Regulations on March 11, 2016 (now the ACMPR). Supreme is one of the newest marijuana Licensed Producers (LP) in Canada’s marijuana market, and is well positioned with its high capacity innovative hybrid greenhouse and B2B focused business model.

You are here

Supreme Pharmaceuticals Inc. (SL)

SEDAR Information

Company Info

Address
202-20 De Boers Drive
Toronto, ON M3J 0H1
Canada
Phone
416-630-7272
Fax
--
Email
info@supreme.ca
Website
http://www.supreme.ca
Listing date
Monday, April 21, 2014

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
154,738,782
Reserved for Issuance: 
96,765,713

Bulletins

01/06/2017

2017-0601 - Delist - Supreme Pharmaceuticals Inc. (SL)

June 1, 2017

The common shares of Supreme Pharmaceuticals Inc. will be delisted at the market close, June 5, 2017.

Supreme Pharmaceuticals will continue to trade on the TSX Venture Exchange.

Date: Market close, June 5, 2017
Symbol: SL

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

06_19_CSE_Present_eSports_Website_V3

CSE Presents: esports in the Capital Markets

Wednesday, June 19, 2019 -
2:00pm to 6:00pm
06_20_Think_Diversification_Website

Thinking North Presents: Think: Diversification

Thursday, June 20, 2019 -
5:00pm to 8:00pm
06_26_The_Cannabis_Society_1x1_Website

The Cannabis Society 1X1 Executive Conference

Wednesday, June 26, 2019 -
1:00pm to 5:30pm